Joel Lim

Joel Lim

InvestorPlace Contributor

Joel Lim is a contributor at InvestorPlace.com and a finance content contractor who creates content for several companies like LTSE and Realtor, along with financial publications, including Business Insider, Yahoo Finance, Mises Institution and Foundation for Economic Education.

He makes content for all types of audiences, ranging from B2B companies to institutional investors and more.

He graduated with a Bachelor’s degree in business from Western Governors University and resides in the Greater Seattle Area.

Recent Articles

3 Strong Buy Biotech Stocks to Add to Your Q2 Must-Watch List

By Joel Lim, InvestorPlace Contributor

Don’t miss out on these three strong buy biotech stocks that are leaders to add to your portfolio for Q2 this year.

3 Sorry Big Data Stocks to Sell in March While You Still Can

By Joel Lim, InvestorPlace Contributor

Find out why now is the time to dump these big data stocks to sell before stunted revenue growth and overvaluations tank their prices.

3 Stocks at Risk of a Dividend Cut: March 2024

By Joel Lim, InvestorPlace Contributor

These companies promise high dividends but are stocks at risk of a dividend cut due to recent performance and earnings-to-payout ratios.

3 Biopharma Stocks Predicted to Soar in Q2 2024

By Joel Lim, InvestorPlace Contributor

These biopharma stocks can produce massive returns for Q2 based on new product releases and international treatment approvals.

Hot Stocks: The 3 Best Opportunities for Investing in Cannabis

By Joel Lim, InvestorPlace Contributor

Hot stocks with excellent prospects and fast-growth potential supply retailers in the booming cannabis industry.

Load More